Go Pro
NASDAQ:BRBI

BR Biopharma Q2 2026 Earnings Report

BR Biopharma logo
$11.72 +0.49 (+4.31%)
As of 03:28 PM Eastern
This is a fair market value price provided by Massive. Learn more.

BR Biopharma EPS Results

Actual EPS
$0.09
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

BR Biopharma Revenue Results

Actual Revenue
$25.13 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

BR Biopharma Announcement Details

Quarter
Q2 2026
Time
After Market Closes
Conference Call Date
Thursday, August 6, 2026
Conference Call Time
4:00PM ET

Earnings Documents

BR Biopharma Earnings Headlines

Contrasting BR Biopharma (BRBI) & Its Rivals
Financial Survey: BR Biopharma (BRBI) & The Competition
Iran War WARNING: Something Just Changed
A powerful Middle Eastern government is reportedly asking Trump for U.S. military help against Iran backed forces. One writer says the request echoes a secret January meeting outside Washington, D.C., where an anonymous source described American military protection as part of something much bigger, involving Trump, Iran, and potentially trillions of dollars.tc pixel
BR Biopharma (BRBI) & Its Rivals Head-To-Head Comparison
See More BR Biopharma Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like BR Biopharma? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BR Biopharma and other key companies, straight to your email.

About BR Biopharma

BRBI BR Partners S.A., through its subsidiaries, operates as an investment bank which specializes in providing financial services for entrepreneurs and families principally in Brazil. It offers financial advisory services for mergers and acquisitions, capital markets, board services, shareholders, special situations and restructuring, pre-IPO, and privatization; and wealth management services. BRBI BR Partners S.A. is based in S?o Paulo, Brazil.

View BR Biopharma Profile